Cargando…
MEK5 promotes lung adenocarcinoma
MEK5 acts as an oncogenic driver in mice lung cancer and is pivotal for human lung adenocarcinoma http://ow.ly/M9e830mZb8N
Autores principales: | Sánchez-Fdez, Adrián, Ortiz-Ruiz, María Jesús, Re-Louhau, María Florencia, Ramos, Isabel, Blanco-Múñez, Óscar, Ludeña, Dolores, Abad, Mar, Sánchez-Martín, Manuel, Pandiella, Atanasio, Esparís-Ogando, Azucena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393765/ https://www.ncbi.nlm.nih.gov/pubmed/30442718 http://dx.doi.org/10.1183/13993003.01327-2018 |
Ejemplares similares
-
Clinical, genetic and pharmacological data support targeting the MEK5/ERK5 module in lung cancer
por: Sánchez-Fdez, Adrián, et al.
Publicado: (2021) -
Expression of Erk5 in Early Stage Breast Cancer and Association with Disease Free Survival Identifies this Kinase as a Potential Therapeutic Target
por: Montero, Juan Carlos, et al.
Publicado: (2009) -
Etiopathogenic role of ERK5 signaling in sarcoma: prognostic and therapeutic implications
por: Sánchez-Fdez, Adrián, et al.
Publicado: (2023) -
The WNK1–ERK5 route plays a pathophysiological role in ovarian cancer and limits therapeutic efficacy of trametinib
por: Sánchez‐Fdez, Adrián, et al.
Publicado: (2023) -
Neuregulin expression in solid tumors: Prognostic value and predictive role to anti-HER3 therapies
por: Ocaña, Alberto, et al.
Publicado: (2016)